The purpose of this K23 proposal is to provide Tara I. Chang, MD, MS with the protected time and resources to allow her to pursue the additional training needed to reach her long-term goal of becoming an independent patient-oriented investigator. Dr. Chang is a board-certified nephrologist and trained epidemiologist, and her research focuses on the intersection of cardiovascular disease and chronic kidney disease (CKD). Chronic kidney disease confers an increased risk for cardiovascular morbidity and mortality, and cardiovascular disease is the leading cause of death in CKD. Visit-to-visit blood pressure variability (BPV), defined as variation in blood pressure that occurs over days to months, is emerging as an important risk factor for death and cardiovascular events independent of mean or usual blood pressure in patients without CKD. Relatively little is known about visit-to-visit BPV in patients with CKD, a population at high risk for adverse clinical event. In addition, to date there is no uniform metric used to characterize visit-to-visit BPV. This projet proposes a series of analyses in patients with CKD, including end-stage renal disease (ESRD), to close some of the evidence gaps related to determinants and consequences of visit-to-visit BPV in this population.
The specific aims of this project are to define the best metrics of visit-t-visit BPV;better characterize traditional and patient-centered determinants of visit-to-visit BPV; compare the effectiveness of antihypertensive medications on clinical outcomes and evaluate whether differences are mediated by differences in visit-to-visit BPV;and evaluate the incremental prognostic value of visit-to-visit BPV as a novel risk marker beyond systolic, diastolic, or mean arterial blood pressure. The proposed work has high potential to make a significant clinical impact, as completion of the project aims will not only advance the current understanding of visit-to-visit BPV in CKD, but also provide preliminary data on putative risk factors to target in a future intervention trial aimed at lowering visit-to-visit BPV and improving clinical outcomes. Importantly, the proposed work is realistic and feasible within the award period, and will allow Dr. Chang to continue to build research skills, generate preliminary data, create additional collaborative networks, and compete for R01 funding. In summary, the K23 award will support the proposed training and career development activities to allow Dr. Chang to launch successfully into the next phase of her career as an independent clinical investigator.

Public Health Relevance

Blood pressure can fluctuate a great deal from one day to the next (a phenomenon known as visit-to-visit blood pressure variability), and this variability may be a risk factor for heart disease, stroke, death, and other important clinical outcomes. Currently, not much is known about visit-to-visit blood pressure variability, particularly in persos with kidney disease, who are at very high risk of cardiovascular disease and other adverse outcomes. The current proposal aims to shed some light on this important topic by evaluating the determinants and consequences of visit-to-visit blood pressure variability in persons with kidney disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
1K23DK095914-01A1
Application #
8581432
Study Section
Special Emphasis Panel (ZDK1-GRB-G (M2))
Program Officer
Rankin, Tracy L
Project Start
2013-08-20
Project End
2018-05-31
Budget Start
2013-08-20
Budget End
2014-05-31
Support Year
1
Fiscal Year
2013
Total Cost
$179,610
Indirect Cost
$12,340
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Franz, Douglas; Zheng, Yuanchao; Leeper, Nicholas J et al. (2018) Trends in Rates of Lower Extremity Amputation Among Patients With End-stage Renal Disease Who Receive Dialysis. JAMA Intern Med 178:1025-1032
Itoga, Nathan K; Tawfik, Daniel S; Lee, Charles K et al. (2018) Association of Blood Pressure Measurements With Peripheral Artery Disease Events. Circulation 138:1805-1814
Haase, Sarah B; Chang, Steven; Schiller, Brigitte et al. (2018) Antihypertensive medication withholding practices in hemodialysis: A survey study of patients and providers. Hemodial Int 22:415-418
Seong, Eun Young; Zheng, Yuanchao; Winkelmayer, Wolfgang C et al. (2018) The Relationship between Intradialytic Hypotension and Hospitalized Mesenteric Ischemia: A Case-Control Study. Clin J Am Soc Nephrol 13:1517-1525
Niu, Jingbo; Shah, Maulin K; Perez, Jose J et al. (2018) Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD. Am J Kidney Dis :
Shen, Jenny I; Saxena, Anjali B; Montez-Rath, Maria E et al. (2017) Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis. J Nephrol 30:281-288
Fung, Enrica; Chang, Tara I; Chertow, Glenn M et al. (2017) Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD. Am J Kidney Dis 70:705-714
Chang, Tara I (2017) Impact of drugs on intradialytic hypotension: Antihypertensives and vasoconstrictors. Semin Dial 30:532-536
Chang, Tara I; Reboussin, David M; Chertow, Glenn M et al. (2017) Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension 70:751-758
Lenihan, Colin R; Montez-Rath, Maria E; Winkelmayer, Wolfgang C et al. (2017) Drug-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Kidney Transplant Recipients. Transplantation 101:851-857

Showing the most recent 10 out of 28 publications